Tablet twinning tendency during scale-up – coating process optimization plan



Published on 26/01/2026

Addressing Tablet Twinning Tendency During Scale-Up: A Process Optimization Plan

The tablet manufacturing process can be fraught with challenges, particularly during scale-up, where the phenomenon of tablet twinning can severely impact product quality and yield. Pharmaceutical professionals are often faced with the demanding task of ensuring consistent coating performance while optimizing manufacturing conditions. This article will provide insights and practical strategies for identifying and addressing tablet twinning tendency in the coating process, resulting in enhanced product quality and compliance with regulatory standards.

By following the outlined problem-solving framework, readers will be equipped to implement immediate containment actions, conduct effective investigations, and develop a comprehensive corrective and preventive action (CAPA) strategy that addresses the root causes of twinning during scale-up. This will ultimately lead to improved yield and enhanced manufacturing excellence.

Symptoms/Signals on the Floor or in the Lab

Recognizing the symptoms of tablet twinning tendency is critical to initiating corrective actions. Common signals observed during the

manufacturing process include:

  • Visual Inspection: Tablets exhibit adhered pairs, creating a fused appearance.
  • Cohesive Weight: Inconsistent weight distribution among batches may indicate aggregation.
  • Visual Coating Anomalies: Uneven or inconsistent coating thickness, resulting in poor aesthetic and functional properties.
  • Deviations in Dissolution Profiles: Unexpected changes in the dissolution rate observed during routine quality control tests.
  • Abnormal Yield Rates: Lower than expected yield compared to historical data, indicating potential rework or loss.

These symptoms signal a need for urgent investigation, as failure to adequately address them may lead to non-compliance with FDA, EMA, or MHRA standards, and negatively affect overall process optimization.

Likely Causes

Understanding the potential causes of tablet twinning tendency is paramount for effective troubleshooting. We can categorize these causes into likely domains, including:

Materials

  • Coating Material Quality: Inconsistencies in polymer characteristics can lead to poor coating adhesion.
  • Excipient Interactions: Changes in excipient properties may cause complications during the coating phase.

Method

  • Coating Process Parameters: Inadequate control of parameters like spray rate and atomization techniques can lead to non-uniform coating.
  • Insufficient Mixing: Poorly mixed formulations can lead to uneven distribution of the coating material.
Pharma Tip:  Inlet air imbalance during continuous coating – process robustness improvement

Machine

  • Equipment Calibration: Improperly calibrated or malfunctioning coating equipment may not achieve desired application outcomes.
  • System Design:** Design flaws in the coater can lead to differential airflow patterns affecting tablet behavior during coating.

Man

  • Operator Errors: Lack of training or adherence to protocols may lead to deviations in coating technique.
  • Handling Practices: Improper handling between processing steps can cause damage or aggregation of tablets.

Measurement

  • Inaccurate Monitoring: Reliance on imprecise measurement tools can result in incorrect assessments of process parameters.
  • Inadequate Trending Analysis: Failing to analyze historical data may lead to oversight of developing trends correlating with twinning.

Environment

  • Humidity Control: Elevated humidity levels can impact powder flow and adhesion quality during coating.
  • Temperature Variability: Fluctuating temperature can affect viscosity and drying rates of coating materials, leading to incomplete coating coverage.

Immediate Containment Actions

In cases where symptoms of tablet twinning are detected, immediate containment actions are essential. These should be performed within the first 60 minutes upon discovery. Key actions include:

  • Halt Production: Immediately cease the coating operation to prevent further production of defective tablets.
  • Isolate Affected Batches: Segregate affected batches and label them clearly to avoid unintended use.
  • Notify Quality Assurance (QA) and Engineering: Incident reporting should be promptly made per internal protocols.
  • Document Initial Findings: Record initial observations, symptoms, and conditions leading to the incident to build a foundation for investigation.

These actions are vital to ensure that the quality standards remain intact and to minimize potential financial losses due to defective products.

Investigation Workflow

A thorough investigation must follow as part of the containment strategy. The workflow should include:

1. Data Collection: Gather relevant data from the coating batch records, operational logs, and environmental conditions. Ensure to focus on:

  • Process parameters (temperature, humidity, spray rate)
  • Material characteristics (viscosity, adhesion properties)
  • Operator actions and adherence to SOPs

2. Data Analysis: Analyze the collected data to identify whether specific trends correlate with the occurrence of twinning. Utilize tools like Statistical Process Control (SPC) to assist in trend analysis.

3. Hypothesis Testing: Formulate hypotheses that explain the twinning phenomenon based on evidence collected. Ensure to cross-reference findings against potential underlying causes identified earlier.

Root Cause Tools

To pinpoint the root cause of tablet twinning, various root cause analysis (RCA) tools can be employed. The selection of which tool to use is context-dependent:

Pharma Tip:  Inlet air imbalance post-validation – regulatory inspection-ready enhancement

5-Why Analysis

This technique promotes a deep-dive exploration of causative factors by asking “why” repeatedly, typically five times. It is effective in straightforward scenarios where the problem appears to stem from operational errors or simple process changes.

Fishbone Diagram

Ideal for identifying various potential causes across multiple categories, utilizing a visual format helps teams collaboratively explore issues. It is particularly useful in complex environments where multiple factors may contribute to the twinning tendency.

Fault Tree Analysis

This method employs a top-down approach by outlining possible failure points methodically. It is especially valuable for understanding interactions between system components that result in twinning.

Select the appropriate tool based on the nature of the problem, the complexity of the manufacturing environment, and who will participate in the analysis. This will yield a clearer understanding of the underlying issues.

Related Reads

CAPA Strategy

Once the root cause has been analyzed, developing an effective CAPA strategy is essential for addressing the identified issues:

Correction

  • Implement immediate corrective measures based on findings (e.g., recalibrating equipment, retraining operators).
  • Document all actions taken to provide an audit trail for regulatory compliance.

Corrective Action

  • Develop long-term strategies to prevent recurrence based on root cause analysis.
  • Consider modifications to processes, equipment, or materials as needed.

Preventive Action

  • Enhance training programs for operators to ensure adherence to new SOPs.
  • Establish a continuous monitoring system to detect early signs of twinning in future manufacturing batches.

Each component should incorporate appropriate documentation ensuring traceability and accountability.

Control Strategy & Monitoring

Following the establishment of CAPA measures, an effective control strategy and ongoing monitoring plan can aid in mitigating future issues:

  • Statistical Process Control (SPC): Utilize SPC charts to track process parameters over time and identify deviations quickly.
  • Regular Sampling: Implement routine testing to quantify the effects of changes made.
  • Alarms and Alerts: Establish automated alerts within monitoring systems to provide warnings when process parameters deviate from set limits.
  • Verification: Regularly verify the consistency of coating through visual inspections and physical attributes.

A robust control strategy should ensure that any emerging trends are promptly addressed before they result in non-compliance issues.

Pharma Tip:  Tablet twinning tendency during film coating – coating process optimization plan

Validation / Re-qualification / Change Control Impact

Investigating the impact of identified issues on validation and re-qualification processes is crucial when considering process modifications:

  • Assess whether changes correlate with existing approved processes or require a full requalification.
  • Ensure to document all changes through a formal change control process and assess their impact on previously validated methods.

This is particularly important to maintain compliance with regulations and safeguard product integrity for commercial batches.

Inspection Readiness: What Evidence to Show

During regulatory inspections, evidencing compliance with quality standards is critical. Ensure to have the following documentation readily available:

  • Records of Investigation: Detailed reports on symptoms, containment actions, investigations, and findings.
  • CAPA Documentation: Clearly articulate corrections made and strategies implemented to prevent future occurrences.
  • Batch Records and Logs: Complete batch records exhibiting process parameters, material batch numbers, and any deviations noted.
  • Quality Control Data: Results from dissolution, weight, and visual inspections.

Maintaining organized and comprehensive records will alleviate concerns during inspections and demonstrate adherence to GMP principles.

FAQs

What is tablet twinning tendency?

Tablet twinning tendency refers to a phenomenon where tablets adhere to each other during the coating process, leading to visual and functional defects.

What are the common symptoms of tablet twinning?

Common symptoms include adhered pairs of tablets, inconsistent weight distribution, uneven coating thickness, and unexpected dissolution results.

How can I contain the issue of tablet twinning?

Immediate containment actions include halting production, isolating affected batches, and documenting initial findings for investigation.

What tools can I use to investigate root causes?

Useful tools include 5-Why Analysis, Fishbone Diagrams, and Fault Tree Analysis, depending on the complexity of the problem.

What is CAPA in pharmaceutical manufacturing?

CAPA stands for Corrective and Preventive Action, which involves steps to correct identified issues and prevent recurrence through effective strategies.

Why is monitoring important in manufacturing?

Continuous monitoring allows for early detection of deviations, ensuring adherence to quality standards and compliance during production.

When should I consider requalification?

Requalification may be necessary when introducing significant changes to the manufacturing process or when previous processes fail to yield acceptable results due to quality issues.

What documentation is required for inspection readiness?

Documentation should include investigation reports, complete batch records, CAPA documentation, and quality control data to provide evidence of compliance with GMP requirements.